| Human |
hsa_circ_ANKRD12 |
- |
hsa_circ_102296 |
active tuberculosis |
ANKRD12 |
hsa‐miR‐578, hsa‐miR‐429, hsa‐miR‐449a, hsa‐miR‐449b‐5p, hsa‐miR‐34c‐5p |
Q
M
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
- |
ovarian cancer |
ANKRD12 |
hsa-miR-4768-5p |
Q
S
| UN |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0000826 |
circ_0000826 |
colorectal cancer |
ANKRD12 |
- |
Q
H
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
bile duct cancer |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
cholangiocarcinoma |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
gallbladder carcinoma |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
pancreatic adenocarcinoma |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
periampullary adenocarcinoma |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12 |
colorectal cancer |
ANKRD12 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0046854 |
- |
gastric cancer |
ANKRD12 |
miR-511-3p |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0003865 |
circANKRD12 |
Hirschsprung disease |
ANKRD12 |
miR-181b-5p |
Q
| DN |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0000826 |
circANKRD12 / circ-ANKRD12 |
myocardial infarction |
ANKRD12 |
hsa-miR-876-5p, hsa-miR-452-3p, hsa-miR-3167, hsa-miR-143-3p, hsa-miR-130b-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0000826 |
circular Ankyrin Repeat Domain 12 / circANKRD12 |
vascular disorder |
ANKRD12 |
- |
Q
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0000826 |
circANKRD12 |
amyotrophic lateral sclerosis |
ANKRD12 |
- |
Q
| DS |
More |
| Human |
hsa_circ_ANKRD12 |
- |
circANKRD12(S8).1 |
COVID-19 |
ANKRD12 |
- |
S
| UP |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0000826 |
Circ_0000826 |
colorectal cancer |
ANKRD12 |
- |
Q
H
S
M
| DN |
More |
| Human |
hsa_circ_ANKRD12 |
hsa_circ_0108942 |
Circ_0108942 |
breast cancer |
ANKRD12 |
miR-1178-3p |
Q
| UP |
More |